Similar results have been described recently, in MDS patients with concurrent SF3B1 and del(5q) aberrations, where SF3B1 mutations were shown to be present in CD34+CD38−CD90+ stem cells in these patients15. Here, SF3B1 is linked to myelodysplastic syndrome.